Yuhan Strikes Long-Awaited Lung Cancer Deal Through Huge Janssen Alliance

License agreement
Yuhan Licenses Out Novel EGFR-TKI To Janssen • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from South Korea

More from Focus On Asia